Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Self-Efficacy as a Predictor of Self-Reported Physical, Cognitive, and Social Functioning in Multiple Sclerosis.
Telemedicine for Monitoring MS Activity and Progression.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level: Commentary.
Multiple sclerosis: a review of the disease and treatment options.
MicroRNA-145 as one negative regulator of astrogliosis.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Neuroimaging of dementia.
Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England : Results of a Modified Prescription-Event Monitoring Study.
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.
Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
Altered topological organization of white matter structural networks in patients with neuromyelitis optica.
The story of neuromyelitis optica continues to be written.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Bilateral differences in lower-limb performance in individuals with multiple sclerosis.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
[Current description of multiple sclerosis].
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.

Pages